Recombinant follicle stimulating hormone vs urinary‐derived gonadotrophins
OHSS · ovulation induction in polycystic ovarian syndrome
It is very uncertain whether recombinant follicle stimulating hormone changes incidence of OHSS per woman compared with urinary‐derived gonadotrophins (very low certainty).
1 finding from 1 review
- Gonadotrophins for ovulation induction in women with polycystic ovary syndrome 2019 · Cochrane Headline outcomes onlyRR 1.48 [0.82, 2.65]10 studies · 1565 participantsVery low